• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用体外杀菌筛选法检测表型药物耐受结核分枝杆菌的抑制剂。

Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen.

机构信息

School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.

出版信息

J Microbiol. 2013 Oct;51(5):651-8. doi: 10.1007/s12275-013-3099-4. Epub 2013 Jun 25.

DOI:10.1007/s12275-013-3099-4
PMID:23800952
Abstract

Many whole cell screens of chemical libraries currently in use are based on inhibition of bacterial growth. The goal of this study was to develop a chemical library screening model that enabled detection of compounds that are active against drug-tolerant non-growing cultures of Mycobacterium tuberculosis. An in vitro model of low metabolically active mycobacteria was established with 8 and 30 day old cultures of M. smegmatis and M. tuberculosis, respectively. Reduction of resazurin was used as a measure of viability and the assay was applied in screens of chemical libraries for bactericidal compounds. The model provided cells that were phenotypically-resilient to killing by first and second-line clinical drugs including rifampicin. Screening against chemical libraries identified proteasome inhibitors, NSC310551 and NSC321206, and a structurally-related series of thiosemicarbazones, as having potent killing activity towards aged cultures. The inhibitors were confirmed as active against virulent M. tuberculosis strains including multi- and extensively-drug resistant clinical isolates. Our library screen enabled detection of compounds with a potent level of bactericidal activity towards phenotypically drug-tolerant cultures of M. tuberculosis.

摘要

许多当前使用的化学文库的全细胞筛选都是基于抑制细菌生长。本研究的目的是开发一种化学文库筛选模型,能够检测对结核分枝杆菌药物耐受非生长培养物有活性的化合物。通过分别用 8 天和 30 天龄的耻垢分枝杆菌和结核分枝杆菌建立低代谢活性分枝杆菌的体外模型。使用 Resazurin 减少作为活力的衡量标准,并将该测定应用于化学文库中杀菌化合物的筛选。该模型提供了对一线和二线临床药物(包括利福平)具有表型抗性的细胞。针对化学文库的筛选鉴定出蛋白酶体抑制剂 NSC310551 和 NSC321206,以及一系列结构相关的硫代卡巴肼,对老龄培养物具有很强的杀伤活性。抑制剂被证实对包括多药和广泛耐药的临床分离株在内的毒力结核分枝杆菌菌株具有活性。我们的文库筛选能够检测对结核分枝杆菌表型药物耐受培养物具有强大杀菌活性的化合物。

相似文献

1
Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen.采用体外杀菌筛选法检测表型药物耐受结核分枝杆菌的抑制剂。
J Microbiol. 2013 Oct;51(5):651-8. doi: 10.1007/s12275-013-3099-4. Epub 2013 Jun 25.
2
Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.用于筛选抗结核化合物以对抗休眠和活跃生长的结核分枝杆菌、牛分枝杆菌卡介苗和耻垢分枝杆菌的刃天青还原试验。
J Antimicrob Chemother. 2007 Aug;60(2):288-93. doi: 10.1093/jac/dkm207. Epub 2007 Jun 22.
3
Targeting Phenotypically Tolerant Mycobacterium tuberculosis.针对表型耐受的结核分枝杆菌。
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TBTB2-0031-2016.
4
Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.评估耻垢分枝杆菌和卡介苗模型用于发现结核分枝杆菌抑制剂。
Tuberculosis (Edinb). 2010 Nov;90(6):333-7. doi: 10.1016/j.tube.2010.09.002. Epub 2010 Oct 12.
5
Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery.靶向结核分枝杆菌药物研发中的染色体分配蛋白 ParA。
J Antimicrob Chemother. 2010 Nov;65(11):2347-58. doi: 10.1093/jac/dkq311. Epub 2010 Sep 1.
6
Antimycobacterial screening of traditional medicinal plants using the microplate resazurin assay.采用微量板 Resazurin assay 对传统药用植物进行抗分枝杆菌筛选。
Can J Microbiol. 2010 Jun;56(6):487-94. doi: 10.1139/w10-035.
7
Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.评价耻垢分枝杆菌作为筛选对耐多药结核分枝杆菌有活性分子的可能替代筛选方法。
J Gen Appl Microbiol. 2007 Dec;53(6):333-7. doi: 10.2323/jgam.53.333.
8
Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.抗结核化合物库筛选鉴定出新型结核分枝杆菌ATP合酶抑制剂。
Tuberculosis (Edinb). 2018 Jan;108:56-63. doi: 10.1016/j.tube.2017.10.008. Epub 2017 Oct 25.
9
Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs.评估BACTEC MGIT 960系统和刃天青微量滴定法用于结核分枝杆菌对二线药物药敏试验的情况。
J Microbiol Methods. 2017 Aug;139:168-171. doi: 10.1016/j.mimet.2017.06.007. Epub 2017 Jun 7.
10
Filtration improves the performance of a high-throughput screen for anti-mycobacterial compounds.过滤可提高抗分枝杆菌化合物高通量筛选的性能。
PLoS One. 2014 May 2;9(5):e96348. doi: 10.1371/journal.pone.0096348. eCollection 2014.

引用本文的文献

1
High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery.用于抗菌药物发现的天然产物和合成分子文库的高通量筛选
Metabolites. 2023 May 2;13(5):625. doi: 10.3390/metabo13050625.
2
Identification of small molecules targeting homoserine acetyl transferase from Mycobacterium tuberculosis and Staphylococcus aureus.鉴定结核分枝杆菌和金黄色葡萄球菌同型半胱氨酸乙酰转移酶的小分子靶向药物。
Sci Rep. 2022 Aug 13;12(1):13801. doi: 10.1038/s41598-022-16468-w.
3
Anti-tuberculosis treatment strategies and drug development: challenges and priorities.

本文引用的文献

1
Growth kinetics of Mycobacterium tuberculosis measured by quantitative resazurin reduction assay: a tool for fitness studies.定量 Resazurin 还原测定法测定结核分枝杆菌的生长动力学:适合研究的工具。
Braz J Microbiol. 2010 Apr;41(2):300-3. doi: 10.1590/S1517-83822010000200006. Epub 2010 Jun 1.
2
Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.链霉素饥饿的结核分枝杆菌 18b,潜伏性结核药物发现的工具。
Antimicrob Agents Chemother. 2012 Nov;56(11):5782-9. doi: 10.1128/AAC.01125-12. Epub 2012 Aug 27.
3
Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection.
抗结核治疗策略和药物研发:挑战与优先事项。
Nat Rev Microbiol. 2022 Nov;20(11):685-701. doi: 10.1038/s41579-022-00731-y. Epub 2022 Apr 27.
4
Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products.海洋天然产物对休眠结核分枝杆菌的选择性杀伤作用
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00743-17. Print 2017 Aug.
5
Targeting Phenotypically Tolerant Mycobacterium tuberculosis.针对表型耐受的结核分枝杆菌。
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TBTB2-0031-2016.
6
Optimization and Evaluation of 5-Styryl-Oxathiazol-2-one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents.优化和评价 5-取代基-氧杂噻唑-2-酮结核分枝杆菌蛋白酶体抑制剂作为潜在抗结核药物。
ChemistryOpen. 2015 Jun;4(3):342-62. doi: 10.1002/open.201500001. Epub 2015 Apr 17.
7
The use of resazurin as a novel antimicrobial agent against Francisella tularensis.利用试卤灵作为一种新型抗弗朗西斯菌药物。
Front Cell Infect Microbiol. 2013 Dec 6;3:93. doi: 10.3389/fcimb.2013.00093. eCollection 2013.
利用全基因组测序估算潜伏性结核分枝杆菌感染期间的突变率。
Nat Genet. 2011 May;43(5):482-6. doi: 10.1038/ng.811. Epub 2011 Apr 24.
4
How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology.结核分枝杆菌在潜伏期内的休眠程度如何?一项整合基因组学和分子流行病学的研究。
Infect Genet Evol. 2011 Jul;11(5):1164-7. doi: 10.1016/j.meegid.2011.02.002. Epub 2011 Feb 18.
5
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.合成与评价新型糖基二硫代氨基甲酸酯类化合物的抗结核活性。
Bioorg Med Chem Lett. 2011 Feb 1;21(3):899-903. doi: 10.1016/j.bmcl.2010.12.084. Epub 2010 Dec 22.
6
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis.用于测试抗非复制分枝杆菌结核分枝杆菌药物的简单模型。
Antimicrob Agents Chemother. 2010 Oct;54(10):4150-8. doi: 10.1128/AAC.00821-10. Epub 2010 Aug 2.
7
Experimental models used to study human tuberculosis.用于研究人类结核病的实验模型。
Adv Appl Microbiol. 2010;71:75-89. doi: 10.1016/S0065-2164(10)71003-0. Epub 2010 Feb 20.
8
Discovery of novel proteasome inhibitors using a high-content cell-based screening system.利用高内涵细胞筛选系统发现新型蛋白酶体抑制剂。
PLoS One. 2009 Dec 30;4(12):e8503. doi: 10.1371/journal.pone.0008503.
9
Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省耐多药和广泛耐药结核的基因组分析。
PLoS One. 2009 Nov 5;4(11):e7778. doi: 10.1371/journal.pone.0007778.
10
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.改变化学文库筛选中的培养条件可鉴定分枝杆菌的替代抑制剂。
Antimicrob Agents Chemother. 2009 Dec;53(12):5279-83. doi: 10.1128/AAC.00803-09. Epub 2009 Sep 28.